Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Stella

Recruiting

Back to Refractory Angina trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(95 sites)

United States

Mayo Clinic, Phoenix, Arizona

HonorHealth Research Institute, Scottsdale, Arizona

University of Arizona Sarver Heart Center, Tucson, Arizona

Long Beach VA Medical Center, Long Beach, California

Cedars-Sinai, Los Angeles, California

Key details

Sponsor

Shockwave Medical, Inc.

Enrollment target

~380 participants

Started

January 2022

Primary completion

July 2027

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov